Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Paganelli

Showing results (11-20 of 213) with videos related to

Pageof 22
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2013
PET/CT and breast cancer subtypesLaura Gilardi, Marco Colleoni, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2017
Reply to: Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imagingGiovanni Paganelli, Maddalena Sansovini, Emanuela Scarpi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
Receptor radionuclide therapy of tumors: a road from basic research to clinical applicationsLisa Bodei, Giovanni Paganelli, Giuliano Mariani
European Journal of Nuclear Medicine and Molecular Imaging|October 16, 2007
Contralateral or bilateral lymph drainage revealed by breast lymphoscintigraphyGiuseppe Trifirò, Laura Ravasi, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2020
A metastatic tumor is no different to a viral pandemic: lessons learnt from COVID-19 may teach us to change the PRRT paradigmGiovanni Paganelli, Lisa Bodei, Irvin Modlin
PET Clinics|July 18, 2014
Yttrium-based therapy for neuroendocrine tumorsLisa Bodei, Marta Cremonesi, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|September 9, 2011
Are we ready for an early evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?Laura Gilardi, Concetta De Cicco, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|September 15, 2012
Preoperative FDG PET/CT in breast cancer patients: where are we going?Laura Gilardi, Concetta De Cicco, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|July 12, 2014
Evaluation of response to immunotherapy: new challenges and opportunities for PET imagingLaura Gilardi, Chiara Maria Grana, Giovanni Paganelli
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Hematologic toxicity and double autografting of stem cells after myeloablative activities of yttrium-90-ibritumomab tiuxetanAnna Vanazzi, Marta Cremonesi, Giovanni Paganelli, et al.
Pageof 22

Showing results (11-20 of 213) with videos related to

Sort By:
Pageof 22
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2013
PET/CT and breast cancer subtypesLaura Gilardi, Marco Colleoni, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2017
Reply to: Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imagingGiovanni Paganelli, Maddalena Sansovini, Emanuela Scarpi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
Receptor radionuclide therapy of tumors: a road from basic research to clinical applicationsLisa Bodei, Giovanni Paganelli, Giuliano Mariani
European Journal of Nuclear Medicine and Molecular Imaging|October 16, 2007
Contralateral or bilateral lymph drainage revealed by breast lymphoscintigraphyGiuseppe Trifirò, Laura Ravasi, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2020
A metastatic tumor is no different to a viral pandemic: lessons learnt from COVID-19 may teach us to change the PRRT paradigmGiovanni Paganelli, Lisa Bodei, Irvin Modlin
PET Clinics|July 18, 2014
Yttrium-based therapy for neuroendocrine tumorsLisa Bodei, Marta Cremonesi, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|September 9, 2011
Are we ready for an early evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?Laura Gilardi, Concetta De Cicco, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|September 15, 2012
Preoperative FDG PET/CT in breast cancer patients: where are we going?Laura Gilardi, Concetta De Cicco, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|July 12, 2014
Evaluation of response to immunotherapy: new challenges and opportunities for PET imagingLaura Gilardi, Chiara Maria Grana, Giovanni Paganelli
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Hematologic toxicity and double autografting of stem cells after myeloablative activities of yttrium-90-ibritumomab tiuxetanAnna Vanazzi, Marta Cremonesi, Giovanni Paganelli, et al.
Pageof 22